Peregrine Capital Management LLC Sells 19,453 Shares of Guardian Pharmacy Services, Inc. $GRDN

Peregrine Capital Management LLC trimmed its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 8.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 201,603 shares of the company’s stock after selling 19,453 shares during the period. Peregrine Capital Management LLC owned about 0.32% of Guardian Pharmacy Services worth $7,592,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. CSM Advisors LLC boosted its holdings in shares of Guardian Pharmacy Services by 40.9% in the third quarter. CSM Advisors LLC now owns 135,665 shares of the company’s stock valued at $3,559,000 after purchasing an additional 39,360 shares during the period. SG Americas Securities LLC grew its stake in Guardian Pharmacy Services by 274.9% in the fourth quarter. SG Americas Securities LLC now owns 19,017 shares of the company’s stock worth $572,000 after purchasing an additional 13,945 shares in the last quarter. Aristotle Capital Boston LLC increased its holdings in Guardian Pharmacy Services by 58.5% during the 3rd quarter. Aristotle Capital Boston LLC now owns 649,463 shares of the company’s stock worth $17,035,000 after purchasing an additional 239,790 shares during the period. Jennison Associates LLC bought a new stake in Guardian Pharmacy Services during the 4th quarter valued at $3,489,000. Finally, TimesSquare Capital Management LLC raised its position in Guardian Pharmacy Services by 21.9% during the 4th quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock valued at $31,538,000 after purchasing an additional 187,963 shares in the last quarter.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN opened at $42.23 on Thursday. The company’s 50-day simple moving average is $39.02 and its 200-day simple moving average is $35.22. Guardian Pharmacy Services, Inc. has a fifty-two week low of $19.30 and a fifty-two week high of $44.00. The stock has a market capitalization of $2.10 billion, a P/E ratio of 50.87, a P/E/G ratio of 2.75 and a beta of 0.05.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The firm had revenue of $336.60 million during the quarter, compared to analyst estimates of $329.89 million. During the same quarter in the previous year, the business posted $0.22 EPS. Guardian Pharmacy Services’s revenue was up 2.2% on a year-over-year basis. On average, research analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on GRDN shares. Bank of America increased their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Jefferies Financial Group assumed coverage on shares of Guardian Pharmacy Services in a research note on Monday, March 30th. They issued a “buy” rating and a $44.00 price objective for the company. UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Oppenheimer upped their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Finally, Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $42.83.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.